fda warning glp-1 november 2025 Beyond the Headlines: Letters to Compounders The Wegovy® Pill: Side Effects,

The global GLP-1 market is on a significant growth trajectory, anticipated to rise from an estimated $44.5 million in 2023 to $95.4 million by 2031,...

Plant-Based Diet: Whether the goal is blood sugar control or weight management, adopting a predominantly plant-based diet offers numerous health advantages

People with alcohol use disorder and obesity drank less when treated with a GLP-1 drug in addition to cognitive behavioral therapy.

Since 2009, new therapies have joined the treatment algorithm for the management of hyperglycaemia in type 2 diabetes

Glucagon-like peptide-1 receptor agonists (GLP-1RA) have shown potent metabolic benefits in type 2 diabetes (T2D) and obesity, but their efficacy and safety in CS remain unexplored

Though PAs are utilized by both Commercial and Medicare payers, it is far less common to see PAs in Medicare and thus have a more meaningful impact